摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-Dimethyl-4-nitro-benzaldehyde | 352278-83-2

中文名称
——
中文别名
——
英文名称
2,6-Dimethyl-4-nitro-benzaldehyde
英文别名
2,6-Dimethyl-4-nitrobenzaldehyde
2,6-Dimethyl-4-nitro-benzaldehyde化学式
CAS
352278-83-2
化学式
C9H9NO3
mdl
——
分子量
179.175
InChiKey
IXQTVZKFAKHUIU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    341.6±30.0 °C(Predicted)
  • 密度:
    1.231±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    62.9
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,6-Dimethyl-4-nitro-benzaldehydepotassium permanganate 作用下, 以 丙酮 为溶剂, 以81%的产率得到2,6-dimethyl-4-nitrobenzoic acid
    参考文献:
    名称:
    2,6-Dimethyl-4-nitrobenzoic Anhydride (DMNBA): An Effective Coupling Reagent for the Synthesis of Carboxylic Esters and Lactones
    摘要:
    Various carboxylic esters are obtained at room temperature in excellent yields with high chemoselectivities from nearly equimolar amounts of carboxylic acids and alcohols using 2,6-dimethyl-4-nitrobenzoic anhydride with triethylamine by the promotion of 4-(dimethylamino)pyridine. The efficiency of the esterification is compared to those of other dehydrations using substituted benzoic anhydrides as coupling reagents. This method was successfully applied to the synthesis of threo-aleuritic acid lactone and the desired 17-membered ring compound was prepared in high yield at room temperature from the corresponding free trihydroxycarboxylic acid using 2,6-dimethyl-4-nitrobenzoic anhydride in the presence of 4-(dimethylamino)pyridine.
    DOI:
    10.3987/com-08-s(n)96
  • 作为产物:
    描述:
    2,6-dimethyl-4-nitrobenzonitrile二异丁基氢化铝 作用下, 以 二氯甲烷 为溶剂, 以89%的产率得到2,6-Dimethyl-4-nitro-benzaldehyde
    参考文献:
    名称:
    2,6-Dimethyl-4-nitrobenzoic Anhydride (DMNBA): An Effective Coupling Reagent for the Synthesis of Carboxylic Esters and Lactones
    摘要:
    Various carboxylic esters are obtained at room temperature in excellent yields with high chemoselectivities from nearly equimolar amounts of carboxylic acids and alcohols using 2,6-dimethyl-4-nitrobenzoic anhydride with triethylamine by the promotion of 4-(dimethylamino)pyridine. The efficiency of the esterification is compared to those of other dehydrations using substituted benzoic anhydrides as coupling reagents. This method was successfully applied to the synthesis of threo-aleuritic acid lactone and the desired 17-membered ring compound was prepared in high yield at room temperature from the corresponding free trihydroxycarboxylic acid using 2,6-dimethyl-4-nitrobenzoic anhydride in the presence of 4-(dimethylamino)pyridine.
    DOI:
    10.3987/com-08-s(n)96
点击查看最新优质反应信息

文献信息

  • Control of selectivity in the generation and reactions of oxonium ylides
    作者:Deana M. Jaber、Ryan N. Burgin、Matthew Hepler、Peter Zavalij、Michael P. Doyle
    DOI:10.1039/c1cc12443a
    日期:——
    Dirhodium catalyzed reactions of aryl-substituted tetrahydropyranone diazoacetoacetates produce ylide intermediates that unexpectedly yield two oxabicyclo[4.2.1]-nonane diastereoisomers, but a single diastereoisomer is formed by increasing the steric bulk of the aryl substituent.
    催化的芳基取代四氢吡喃酮二氟乙酸酯的反应产生了意外的亚胺中间体,这些中间体生成了两种氧杂 bicyclo[4.2.1]-九氢庚烯的差向异构体,但通过增加芳基取代基的立体体积,可以形成单一的差向异构体。
  • Saccharin derivative proteolytic enzyme inhibitors
    申请人:STERLING WINTHROP INC.
    公开号:EP0542371A1
    公开(公告)日:1993-05-19
    Compounds having the structural formula wherein L is N,O or SOn wherein n is 0,1or 2; L-R¹ is a leaving group, H-L-R¹ is the conjugate acid thereof and, when L is N, H-L-R¹ has a pKa value less than or equal to 6, when L is O, H-L-R¹ has a pKa value less than or equal to 8, and when L is SOn, H-L-R¹ has a pKa value less than or equal to 5; R₂ is primary or secondary alkyl of two to four carbon atoms, primary alkylamino of one to three carbon atoms, primary alkylmethylamino of two to four carbon atoms, diethylamino or primary alkoxy of one to three carbon atoms; and R₃ is from one to three of a variety of sustituents at any or all of the 5-, 6- and 7-positions; or a pharmaceutically acceptable acid addition salt thereof if the compound has a basic functional group or a pharmaceutically acceptable base addition salt thereof if the compound has an acidic functional group, which inhibit the enzymatic activity of proteolytic enzymes, and processes for preparation thereof, method of use thereof in treatment of degenerative diseases and pharmaceutical compositions thereof are disclosed.
    结构式如下的化合物 其中 L 是 N、O 或 SOn,其中 n 是 0、1 或 2; L-R¹为离去基团,H-L-R¹为其共轭酸,且 当 L 为 N 时,H-L-R¹ 的 pKa 值小于或等于 6、 当 L 为 O 时,H-L-R¹ 的 pKa 值小于或等于 8,以及 当 L 为 SOn 时,H-L-R¹ 的 pKa 值小于或等于 5; R₂ 是 2 至 4 个碳原子的伯或仲烷基、1 至 3 个碳原子的伯烷基基、2 至 4 个碳原子的伯烷基甲基基、二乙基基或 1 至 3 个碳原子的伯烷氧基;R₃ 是位于 5、6 和 7 位置的任一或全部的各种助位基中的 1 至 3 个; 如果化合物具有碱性官能团,则为其药学上可接受的酸加成盐;如果化合物具有酸性官能团,则为其药学上可接受的碱加成盐、 本发明公开了可抑制蛋白解酶的酶活性的化合物及其制备工艺、用于治疗退行性疾病的方法和药物组合物。
  • Kubota, Tanekazu; Hiramatsu, Sadaaki; Kano, Kenji, Chemical and pharmaceutical bulletin, 1984, vol. 32, # 10, p. 3830 - 3839
    作者:Kubota, Tanekazu、Hiramatsu, Sadaaki、Kano, Kenji、Uno, Bunji、Miyazaki, Hiroshi
    DOI:——
    日期:——
  • US5380737A
    申请人:——
    公开号:US5380737A
    公开(公告)日:1995-01-10
  • US5464852A
    申请人:——
    公开号:US5464852A
    公开(公告)日:1995-11-07
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫